Literature DB >> 3578634

Radionuclide imaging in internal derangements of the knee.

P Mooar, J Gregg, J Jacobstein.   

Abstract

The clinical specificity and sensitivity of imaging with 99mTc was evaluated prospectively in 104 consecutive patients admitted to the hospital for diagnostic/surgical arthroscopy. Four distinct patterns of radionuclide activity were seen that correlated with observed arthroscopic findings. These patterns of activity were seen with degenerative joint disease (DJD) or severe rotational instability, meniscal pathology, fracture of the subchondral plate or full thickness cartilaginous ulceration, and synovitis. Radionuclide imaging was seen to be extremely sensitive and highly specific for all four patterns of activity. The observed association of subchondral plate injury with meniscal pathology may present an explanation for the observed poor outcome in a limited number of patients following meniscectomy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3578634     DOI: 10.1177/036354658701500207

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  4 in total

1.  Three-phase radionuclide bone imaging and magnetic resonance imaging detection of occult knee fractures in athletes.

Authors:  F Giammarile; C Masciocchi; A Barile; M di Pietro; A Carducci; I Baschieri
Journal:  Eur J Nucl Med       Date:  1994-06

2.  Bone imaging after acute knee hemarthrosis.

Authors:  D Fritschy; D M Daniel; D Rossman; C Rangger
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1993       Impact factor: 4.342

3.  Anterior cruciate ligament rupture and osteoarthritis progression.

Authors:  James Min-Leong Wong; Tanvir Khan; Chethan S Jayadev; Wasim Khan; David Johnstone
Journal:  Open Orthop J       Date:  2012-07-27

4.  SPECT imaging in the diagnosis of meniscal tears.

Authors:  M P Grevitt; M Taylor; M Churchill; P Allen; P J Ryan; I Fogelman
Journal:  J R Soc Med       Date:  1993-11       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.